IMGN

Immunogen Inc
IMGN

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

IMGN was delisted on the 9th of February, 2024.

Back to rankings

135 hedge funds and large institutions have $262M invested in Immunogen Inc in 2017 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 40 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less call options, than puts

Call options by funds: $ | Put options by funds: $

44% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 32

Holders
135
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$760K
Puts
$1.09M
Net Calls
Net Calls Change

Top Buyers

1
+$20.7M
2
+$15.4M
3
+$3.42M
4
Ameriprise
Ameriprise
Minnesota
+$1.53M
5
SSA
Schonfeld Strategic Advisors
New York
+$968K

Top Sellers

1
-$4.3M
2
-$4.21M
3
-$3.88M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$900K
5
Two Sigma Investments
Two Sigma Investments
New York
-$708K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$1.7M
27
$1.53M
28
$1.28M
29
$1.16M
30
$1.16M
31
$1.06M
32
$982K
33
$947K
34
$734K
35
$725K
36
$642K
37
$617K
38
$458K
39
$438K
40
$432K
41
$409K
42
$400K
43
$395K
44
$387K
45
$382K
46
$362K
47
$331K
48
$326K
49
$284K
50
$279K
1
2
3 4 5